Sue Gu is a Respiratory physician. OpenAlex indexes 32 publications with 1,609 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
720-848-0000Provider last certified this registry record 28 Oct 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AngioDynamics, Inc.Program year20252 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year20241 payment
- Roche Diagnostics CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55.6%Endothelin Receptor Antagonist33.3%Opsumit52%Ambrisentan48%Part D<11 patientsSoluble Guanylate Cyclase Stimulator22.2%Adempas100%Part D<11 patientsBlood & clotting
44.4%Factor Xa inhibitor27.2%Eliquis100%Part D<11 patientsProstacyclin Receptor Agonist17.3%Uptravi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2025–2026 per NIH RePORTER. The latest:
- Sex Differences in Cardiac Macrophages in Response to Pulmonary Hypertension
University of Colorado Denver
FY2026$163,145K08HL175217 - Sex Differences in Cardiac Macrophages in Response to Pulmonary Hypertension
University of Colorado Denver
FY2025$163,145K08HL175217
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The importance of sex as a biological variable in pulmonary vascular research
American Journal of Physiology-Lung Cellular and Molecular Physiology
2026 - Biological and Clinical Implications of Sex Differences in Right Heart Failure Associated With Pulmonary Arterial Hypertension
Arteriosclerosis Thrombosis and Vascular Biology
2026 - 26-A-8106-ACC INVESTIGATING THE IMMUNE AND STROMAL CHANGES OF THE RIGHT VENTRICLE IN PATIENTS WITH RIGHT HEART FAILURE
Journal of the American College of Cardiology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”